secwatch.observer — SEC 8-K summary
======================================

Issuer:     MASIMO CORP (MASI)
CIK:        0000937556
Form:       8-K
Filed at:   2024-02-27T23:59:59+00:00
Accession:  0000937556-24-000015
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Masimo Q4 revenue $548.9M, GAAP EPS $0.63; full-year $2,048.1M; FY2024 guidance $2,045-2,165M
--------------------------------------------------------------------------------

- Q4 consolidated revenue $548.9M (healthcare $339.9M, non-healthcare $209.0M).
- GAAP EPS $0.63; non-GAAP EPS (updated) $1.25.
- Full-year 2023 revenue $2,048.1M; GAAP EPS $1.51; non-GAAP EPS $3.79.
- Q1 2024 guidance: revenue $476-501M; full-year 2024 revenue $2,045-2,165M.
- CEO cites record contract wins, FDA clearances, and hearables growth as momentum drivers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/937556/000093755624000015/0000937556-24-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/937556/000093755624000015/masi-20240227.htm
  HTML page:      https://secwatch.observer/filing/0000937556-24-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer